Shandong Fengyuan Chemical Co., Ltd. (SHE:002805)
China · Delayed Price · Currency is CNY 26.88
+2.44 (9.98%)
Jun 18, 2026, 3:04 PM CST
SHE:002805 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Revenue | 3,341 | 2,325 | 1,488 | 2,734 | 1,681 | 777.78 |
Other Revenue | 1.48 | 1.48 | 1.28 | 42.86 | 54.25 | 25.27 |
| 3,342 | 2,327 | 1,490 | 2,777 | 1,736 | 803.05 | |
Revenue Growth (YoY) | 98.75% | 56.18% | -46.35% | 59.98% | 116.14% | 124.78% |
Cost of Revenue | 3,391 | 2,565 | 1,770 | 2,999 | 1,422 | 680.86 |
Gross Profit | -49.04 | -238.12 | -280.18 | -222.16 | 314.03 | 122.19 |
Selling, General & Admin | 61.25 | 58.42 | 51.4 | 70.34 | 56.18 | 24.23 |
Research & Development | 89.38 | 73.1 | 23.73 | 29.8 | 14.64 | 9.3 |
Other Operating Expenses | 14.67 | 11.12 | 10.26 | 10.14 | 6.31 | 3.68 |
Operating Expenses | 175.59 | 145.26 | 87.09 | 104.72 | 86.76 | 48.74 |
Operating Income | -224.63 | -383.38 | -367.26 | -326.88 | 227.27 | 73.45 |
Interest Expense | -145.93 | -83.56 | -67.28 | -74.7 | -33.76 | -6.32 |
Interest & Investment Income | 6.92 | 3.72 | 4.93 | 6.17 | 6.24 | 2.79 |
Currency Exchange Gain (Loss) | 0.06 | 0.06 | 0.35 | 0.17 | 0.81 | -0.35 |
Other Non Operating Income (Expenses) | 17.3 | -37.64 | -11.67 | -76.63 | -5.97 | -0.66 |
EBT Excluding Unusual Items | -346.28 | -500.8 | -440.94 | -471.86 | 194.59 | 68.91 |
Gain (Loss) on Sale of Investments | - | - | - | 0.03 | -8.77 | -2.79 |
Gain (Loss) on Sale of Assets | 0.07 | 0.04 | 0.02 | -0.02 | - | - |
Asset Writedown | -65.83 | -66.58 | -24.42 | -61.42 | - | - |
Other Unusual Items | 64.69 | 24.12 | 7.28 | 14.78 | -6.3 | 1.89 |
Pretax Income | -347.35 | -543.22 | -458.06 | -518.49 | 179.53 | 68.01 |
Income Tax Expense | 7.54 | -5.02 | -12.13 | -86.17 | 28.7 | 14.96 |
Earnings From Continuing Operations | -354.9 | -538.2 | -445.93 | -432.33 | 150.82 | 53.05 |
Minority Interest in Earnings | 36.52 | 53 | 83.71 | 43.01 | 0.06 | 0.04 |
Net Income | -318.38 | -485.2 | -362.23 | -389.32 | 150.88 | 53.09 |
Net Income to Common | -318.38 | -485.2 | -362.23 | -389.32 | 150.88 | 53.09 |
Net Income Growth | - | - | - | - | 184.20% | - |
Shares Outstanding (Basic) | 281 | 280 | 280 | 280 | 256 | 225 |
Shares Outstanding (Diluted) | 281 | 280 | 280 | 280 | 256 | 225 |
Shares Change (YoY) | 0.23% | -0.00% | -0.01% | 9.52% | 13.54% | 10.22% |
EPS (Basic) | -1.13 | -1.73 | -1.29 | -1.39 | 0.59 | 0.24 |
EPS (Diluted) | -1.13 | -1.73 | -1.29 | -1.39 | 0.59 | 0.24 |
EPS Growth | - | - | - | - | 150.32% | - |
Free Cash Flow | -345.01 | -362.25 | -263.76 | -1,920 | -2,511 | -305.84 |
Free Cash Flow Per Share | -1.23 | -1.29 | -0.94 | -6.85 | -9.82 | -1.36 |
Dividend Per Share | - | - | - | - | 0.071 | 0.021 |
Dividend Growth | - | - | - | - | 233.65% | - |
Gross Margin | -1.47% | -10.23% | -18.81% | -8.00% | 18.09% | 15.22% |
Operating Margin | -6.72% | -16.48% | -24.65% | -11.77% | 13.09% | 9.15% |
Profit Margin | -9.53% | -20.85% | -24.32% | -14.02% | 8.69% | 6.61% |
Free Cash Flow Margin | -10.32% | -15.57% | -17.71% | -69.13% | -144.64% | -38.09% |
EBITDA | 71.06 | -107.52 | -170.72 | -203.43 | 282.69 | 107.85 |
EBITDA Margin | 2.13% | -4.62% | -11.46% | -7.33% | 16.29% | 13.43% |
D&A For EBITDA | 295.69 | 275.86 | 196.54 | 123.45 | 55.42 | 34.4 |
EBIT | -224.63 | -383.38 | -367.26 | -326.88 | 227.27 | 73.45 |
EBIT Margin | -6.72% | -16.48% | -24.65% | -11.77% | 13.09% | 9.15% |
Effective Tax Rate | - | - | - | - | 15.99% | 22.00% |
Revenue as Reported | 3,342 | 2,327 | 1,490 | 2,777 | 1,736 | 803.05 |
Advertising Expenses | - | 0.59 | 0.11 | 0.05 | 0.22 | 0.07 |